Lincoln Pharma Closes Trading Window for Q1 FY27 Results

Lincoln Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be shut from July 01, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. All directors, senior management, promoters, and connected persons are advised not to trade during this period. The date for the Board of Directors' meeting to approve these financial results will be communicated separately.